Pulsatile Tubular Cardiac Tissues Fabricated by Wrapping Human IPS Cells-derived Cardiomyocyte Sheets

Overview

Journal Regen Ther

Date 2019 Nov 1

PMID 31667209

Citations 18

Authors

Shinpei Tsuruyama

Katsuhisa Matsuura

Katsuhisa Sakaguchi

Tatsuya Shimizu

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to fabricate pulsatile tubular cardiac tissue using cell sheet based-tissue engineering. First, we fabricated human induced pluripotent stem cell (hiPSc)-derived cardiomyocyte sheets and normal human dermal fibroblast (NHDF) sheets which are harvested from temperature responsive culture dishes only by lowering the temperature. Then tubular cardiac tissues are formed by wrapping one hiPSc-derived cardiomyocyte sheet and three NHDF sheets around an octagonal column, and both ends of the tubular tissue were covered with fibrin and collagen gel. The octagonal column with the tubular tissue was connected to an circulation system in a culture box. After four-day culture, the cardiac tissue survived and pulsated spontaneously in the circulation system. Furthermore, the analysis with a Millar catheter inserted into the cardiac tubes revealed significant inner pressure changes generated by their beating. In addition, the tubular cardiac tissue pulsated in response to the electrical stimulation. Although histological analyses demonstrated that cardiac troponin T-positive cells stratified the inner surface of the tubular tissues, gene expression analyses showed an immature state of these cardiomyocytes. Thus, cell sheet-based tissue engineering realized human pulsatile tubular cardiac tissue fabrication and we believe that these tubular cardiac tissues should contribute to future drug screening and regenerative therapy for heart diseases.

Citing Articles

Fabrication of heart tubes from iPSC derived cardiomyocytes and human fibrinogen by rotating mold technology.

Andree B, Voss N, Kriedemann N, Triebert W, Teske J, Mertens M Sci Rep. 2024; 14(1):13174.

PMID: 38849457 PMC: 11161509. DOI: 10.1038/s41598-024-64022-7.

Biomimetic cardiac tissue chip and murine arteriovenous fistula models for recapitulating clinically relevant cardiac remodeling under volume overload conditions.

Isayeva Waldrop T, Graham C, Gard W, Ingle K, Ptacek T, Nguyen N Front Bioeng Biotechnol. 2023; 11:1101622.

PMID: 36873372 PMC: 9978753. DOI: 10.3389/fbioe.2023.1101622.

Recent advances in biological pumps as a building block for bioartificial hearts.

Brimmer S, Ji P, Birla A, Keswani S, Caldarone C, Birla R Front Bioeng Biotechnol. 2023; 11:1061622.

PMID: 36741765 PMC: 9895798. DOI: 10.3389/fbioe.2023.1061622.

A three-dimensional culture system for generating cardiac spheroids composed of cardiomyocytes, endothelial cells, smooth-muscle cells, and cardiac fibroblasts derived from human induced-pluripotent stem cells.

Kahn-Krell A, Pretorius D, Guragain B, Lou X, Wei Y, Zhang J Front Bioeng Biotechnol. 2022; 10:908848.

PMID: 35957645 PMC: 9361017. DOI: 10.3389/fbioe.2022.908848.

The Progress of Stem Cell Therapy in Myocardial-Infarcted Heart Regeneration: Cell Sheet Technology.

Munderere R, Kim S, Kim C, Park S Tissue Eng Regen Med. 2022; 19(5):969-986.

PMID: 35857259 PMC: 9478006. DOI: 10.1007/s13770-022-00467-z.

References

Yamamoto K, Yamato M, Morino T, Sugiyama H, Takagi R, Yaguchi Y . Middle ear mucosal regeneration by tissue-engineered cell sheet transplantation. NPJ Regen Med. 2018; 2:6. PMC: 5665617. DOI: 10.1038/s41536-017-0010-7. View

Holubarsch C, Ruf T, Goldstein D, Ashton R, Nickl W, Pieske B . Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels. Circulation. 1996; 94(4):683-9. DOI: 10.1161/01.cir.94.4.683. View

Seta H, Matsuura K, Sekine H, Yamazaki K, Shimizu T . Tubular Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells Generate Pulse Pressure In Vivo. Sci Rep. 2017; 7:45499. PMC: 5371992. DOI: 10.1038/srep45499. View

Himmel H . Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds. J Pharmacol Toxicol Methods. 2013; 68(1):97-111. DOI: 10.1016/j.vascn.2013.05.005. View

Zhu R, Blazeski A, Poon E, Costa K, Tung L, Boheler K . Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther. 2015; 5(5):117. PMC: 4396914. DOI: 10.1186/scrt507. View

Ohki T, Yamato M, Ota M, Takagi R, Murakami D, Kondo M . Prevention of esophageal stricture after endoscopic submucosal dissection using tissue-engineered cell sheets. Gastroenterology. 2012; 143(3):582-588.e2. DOI: 10.1053/j.gastro.2012.04.050. View

Kubo H, Shimizu T, Yamato M, Fujimoto T, Okano T . Creation of myocardial tubes using cardiomyocyte sheets and an in vitro cell sheet-wrapping device. Biomaterials. 2007; 28(24):3508-16. DOI: 10.1016/j.biomaterials.2007.04.016. View

Sakaguchi K, Shimizu T, Horaguchi S, Sekine H, Yamato M, Umezu M . In vitro engineering of vascularized tissue surrogates. Sci Rep. 2013; 3:1316. PMC: 3575583. DOI: 10.1038/srep01316. View

Nishida K, Yamato M, Hayashida Y, Watanabe K, Yamamoto K, Adachi E . Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med. 2004; 351(12):1187-96. DOI: 10.1056/NEJMoa040455. View

10.

Kim K, Ohashi K, Utoh R, Kano K, Okano T . Preserved liver-specific functions of hepatocytes in 3D co-culture with endothelial cell sheets. Biomaterials. 2011; 33(5):1406-13. DOI: 10.1016/j.biomaterials.2011.10.084. View

11.

Kanzaki M, Takagi R, Washio K, Kokubo M, Yamato M . Bio-artificial pleura using an autologous dermal fibroblast sheet. NPJ Regen Med. 2018; 2:26. PMC: 5677916. DOI: 10.1038/s41536-017-0031-2. View

12.

Iwata T, Yamato M, Washio K, Yoshida T, Tsumanuma Y, Yamada A . Periodontal regeneration with autologous periodontal ligament-derived cell sheets - A safety and efficacy study in ten patients. Regen Ther. 2018; 9:38-44. PMC: 6222282. DOI: 10.1016/j.reth.2018.07.002. View

13.

Zhao Y, Rafatian N, Feric N, Cox B, Aschar-Sobbi R, Wang E . A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling. Cell. 2019; 176(4):913-927.e18. PMC: 6456036. DOI: 10.1016/j.cell.2018.11.042. View

14.

Sasaki D, Matsuura K, Seta H, Haraguchi Y, Okano T, Shimizu T . Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue. PLoS One. 2018; 13(5):e0198026. PMC: 5965888. DOI: 10.1371/journal.pone.0198026. View

15.

Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe K . Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res. 2002; 90(3):e40. DOI: 10.1161/hh0302.105722. View

16.

Lee S, Sasaki D, Kim D, Mori M, Yokota T, Lee H . Ultrasoft electronics to monitor dynamically pulsing cardiomyocytes. Nat Nanotechnol. 2019; 14(2):156-160. DOI: 10.1038/s41565-018-0331-8. View

17.

Tiburcy M, Hudson J, Balfanz P, Schlick S, Meyer T, Chang Liao M . Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair. Circulation. 2017; 135(19):1832-1847. PMC: 5501412. DOI: 10.1161/CIRCULATIONAHA.116.024145. View

18.

Matsuura K, Wada M, Shimizu T, Haraguchi Y, Sato F, Sugiyama K . Creation of human cardiac cell sheets using pluripotent stem cells. Biochem Biophys Res Commun. 2012; 425(2):321-7. DOI: 10.1016/j.bbrc.2012.07.089. View

19.

Sekine H, Shimizu T, Yang J, Kobayashi E, Okano T . Pulsatile myocardial tubes fabricated with cell sheet engineering. Circulation. 2006; 114(1 Suppl):I87-93. DOI: 10.1161/CIRCULATIONAHA.105.000273. View

20.

Miyagawa S, Domae K, Yoshikawa Y, Fukushima S, Nakamura T, Saito A . Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy. J Am Heart Assoc. 2017; 6(4). PMC: 5532985. DOI: 10.1161/JAHA.116.003918. View